baber/WOPTO huggingface dataset:
Patent JP-3946772-B2 (JP)
IPC: B01J45/00
Filed: 1997-08-18
Granted: 2007-07-18
Abstract: Purification of poly-amino acid-tagged recombinant proteins has been improved by the use of a carboxymethylated aspartate ligand complexed with a third-block transition metal having an oxidation state of 2<SUP>+</SUP> and a coordination number of 6. A method for synthesizing the metal ion-CM-Asp complex is also described. Further, the metal ion-CM-Asp complex can be used for screening protein function.
Patent JP-3734261-B2 (JP)
IPC: C08K3/00
Filed: 1992-11-25
Granted: 2006-01-11
Abstract: An aqueous adhesive composition containing a chlorosulfonated polyethylene latex, a polymaleimide compound, a nitroso compound and a metal oxide. The adhesive composition can be effectively utilized without a primer component and exhibits an unusually high resistance to pre-bake conditions and adverse environments. The adhesive also possesses the ability to effectively bond a variety of substrates.
Patent JP-3078575-B2 (JP)
IPC: C07K16/00
Filed: 1990-10-10
Granted: 2000-08-21
Abstract: A method for removing unbound labeling reagent from a composition comprising bound and unbound labeling reagent is described. Lilo-matrix conjugate capable of binding unbound labeling reagent is contacted with a biomolecule labeling reaction mixture and then the labeled biomolecule essentially free of unbound labeling reagent is removed.
Patent JP-3330953-B2 (JP)
IPC: C07K16/40
Filed: 1996-01-12
Granted: 2002-10-07
Abstract: There is disclosed the use of protein C and/or the activation peptide of protein C for preparing a pharmaceutical preparation having anti-nociceptive activity. This pharmaceutical preparation is useful in the treatment of painful conditions caused by acute or chronic inflammatory processes (such as rheumatoid arthritis, myositis, gastritis, colitis, inflammations in the urogenital tract).
Patent JP-4114087-B2 (JP)
IPC: F17C7/04
Filed: 1997-11-20
Granted: 2008-07-09
Abstract: A miniature valve for filling the reservoir of an apparatus for the transdermal administration of a medicine including a) a substrate, b) a fuel charge arranged on the substrate opposite the passage to be opened through it, and c) an electric resistor placed in contact with the fuel charge so that the supply of this resistor with a predetermined electric energy ensures the combustion of the charge and the opening of the passage by local rupture of the substrate under the pressure of the fuel gases of the charge. The device is useful for filling a medicine reservoir for the transdermal administration medicine aided by inophoresis.
Patent JP-3406608-B2 (JP)
IPC: C12Q1/04
Filed: 1995-03-16
Granted: 2003-05-12
Abstract: PCT No. PCT/DK95/00119 Sec. 371 Date Sep. 16, 1996 Sec. 102(e) Date Sep. 16, 1996 PCT Filed Mar. 16, 1995 PCT Pub. No. WO95/25174 PCT Pub. Date Sep. 21, 1995A method is disclosed for conditioning samples (of e.g. milk or meat) containing fat globules and somatic cells and/or protein particles before they are subjected to fluorescence measurements in order to determine the bacterial content, as well as methods for performing the determination of bacterial content in such samples. The conditioning method involves the treatment of the samples with an ion-chelating agent, a proteolytic enzyme, detergent, and a bacteriologically specific fluorochrome such as ethidium bromide. Detergent is used in a concentration resulting in substantially no dissolution of the fat globules and the conditioned samples thus loses insignificant amounts of fat globules. The assessment of fluorescence is preferably performed in a conventional flow cytometer. As no separation of fat globules is necessary, the methods are simple and fast. The bacterial determinations have proved reliable when compared to standard methods.
Patent JP-3585127-B2 (JP)
IPC: A61M15/00
Filed: 1996-03-14
Granted: 2004-11-04
Abstract: PCT No. PCT/EP96/01095 Sec. 371 Date Sep. 10, 1997 Sec. 102(e) Date Sep. 10, 1997 PCT Filed Mar. 14, 1996 PCT Pub. No. WO96/28206 PCT Pub. Date Sep. 19, 1996The invention relates to an ultrasonic atomizer device (2) for a fluid (60), in particular a bronchospasmolytic agent, in which a propelling element (10) operable by an electronic circuit (6) to deliver the fluid to an atomization surface (28) that is also supplied with ultrasound waves from the electronic circuit (6) is provided in a housing (4), the propelling element (10) having a coupling member (32) which is meshing with a further coupling member (34) of a replaceable dosating unit (14) for transferring propelling power to the dosating unit (14) to effect a linear movement (68) of a piston (66) arranged in an ampoule (28) within the dosating unit (14). The invention also relates to a system comprising a device (2) as described and a dosating unit (14) inserted into that device (2).
Patent JP-4162718-B2 (JP)
IPC: A61L2/08
Filed: 1997-12-16
Granted: 2008-10-08
Abstract: A process and installation (1) are claimed for the sterilisation of medical products by irradiation. Products are carried on conveyors (10-21) from a loading station (2) to an unloading station (4), via a casing (6) containing the irradiation station (7). The products are rearranged near the irradiation station. Products are marked with an identification code and are carried on the conveyor on trays, also marked with identification codes. These codes can be read by scanners at various points around the circuit to monitor progress. <??>Three conveyors are arranged in series in the irradiation station. The first and second consist of pairs of chains carrying retractable fingers. When these are extended, they draw products along the conveyor at exactly the same speed as which it is moving, ensuring consistent treatment time. <??>The first conveyor moves slightly slower than the other two. The second is split into two half conveyors, with the sterilising rays being emitted between them. The third conveyor moves faster than the other two, taking products away from the treatment zone without a bottle neck. As the conveyors (11-13 and 18-20) enter and leave the treatment casing (6) one is positioned directly above the other. Ramps are used to raise and lower the levels, as the loading and unloading stations (2 and 4) are at the same level.
Patent JP-4195726-B2 (JP)
IPC: C08F246/00
Filed: 1997-04-30
Granted: 2008-12-10
Abstract: PCT No. PCT/GB97/01173 Sec. 371 Date Apr. 30, 1999 Sec. 102(e) Date Apr. 30, 1999 PCT Filed Apr. 30, 1997 PCT Pub. No. WO97/41164 PCT Pub. Date Nov. 6, 1997Polymers having non-thrombogenic properties can be prepared by copolymerizing monomers of at least three classes selected from (a) monomers having sulphate groups, (b) monomers having sulphonate groups, (c) monomers having sulphamate groups, (d) monomers having polyoxyalkylene ether groups, and (e) monomers having zwitterionic groups. The polymers can additionally be provided with anti-thrombogenic properties by including an additional comonomer having a pendant heparin (or hirudin, warfarin or hyaluronic acid) group. The polymers can be used as coating materials for medical devices, such as tubing or connectors, in order to provide them with non-thrombogenic, and optionally anti-thrombogenic, properties.
Patent JP-4011125-B2 (JP)
IPC: H04W8/06
Filed: 1999-03-29
Granted: 2007-11-21
Abstract: Telecommunication method which enables a subscriber of a home mobile radio network (HPLMN) to connect to a visited mobile radio network (VPLMN, VPLMN') without a roaming agreement with the home mobile radio network (HPLMN) in that the subscriber is assigned a first mobile subscriber identification (IMSI1) from the number range of his home mobile radio network (HPLMN) and a second IMSI number (IMSI2) from the number range of a partner network (PPLMN), the partner network having additional roaming agreements, and a common call number (MSISDN) being allocated to the two said IMSI numbers (IMSI1, IMSI2). The two IMSI numbers (IMSI1, IMSI2) may preferably be stored on a common or on different identification modules.
Patent ES-2211338-B2 (ES)
Title: Sistema para la desalacion de agua basado en energia eolica.
Inventor: LYNG BJORN
IPC: F03D9/28
Filed: 2002-12-20
Granted: 2006-03-16
Abstract: Sistema para la desalación de agua basado en energía eólica, en especial para desalar agua en sistemas aislados carentes de producción de energía eléctrica. El sistema se compone de un molino con una columna (1) móvil, sostenida por una serie de rodillos (2) de sujeción, y estando conectadas las aspas (3) del molino al eje exterior (5) del mismo. Este molino va unido directamente a una bomba de alta presión (6), la cual está conectada a través de una válvula (7) a una turbina (23) unida a la bomba (11) de extracción de agua de un pozo. El agua es transportada a un depósito (9) y parte de ella retorna a la bomba de la alta presión (6) y el resto accede a un sistema de recuperación de energía (15). Está previsto un sistema (13) dotado de una miniturbina (8) y una bomba auxiliar (12) y conectado con un sistema de membranas de ósmosis inversa (14) que queda unido a un depósito de agua potable (18).
Patent ES-2529369-B2 (ES)
Title: Uso del compuesto 2,5-dihidroxibencenosulfonato de calcio (calcio dobesilato) para la elaboracion de un medicamento para el tratamiento de la acondroplasia
Inventor: CASTRO BUGARIN ANA
IPC: A61P19/08
Filed: 2013-07-09
Granted: 2015-10-14
Abstract: La presente invención describe la aplicación del 2,5-dihidroxibencenosulfonato de calcio (calcio dobesilato) para el tratamiento de la acondroplasia (enanismo). La aplicación del 2,5-dihidroxibencenosulfonato de calcio (calcio dobesilato) es capaz de reducir el nivel de fosforilación de las proteínas ERK1/2 que están anormalmente elevadas en la acondroplasia y causa los efectos característicos del enanismo. El efecto del 2,5-dihidroxibencenosulfonato de calcio (calcio dobesilato) reduciendo la fosforilación de ERK1/2 está relacionado con la disminución de los efectos patológicos asociados a esta enfermedad.
Patent AU-2001272862-B2 (AU)
Title: Device for conveying products
Inventor: SORENSEN PER
IPC: B65G59/06
Filed: 2001-07-13
Granted: 2005-06-16
Abstract: The invention relates to a device for controlled conveying of products ( 2 ), such as drinks cans or bottles from an intake ( 3 ) at a first height level to an outlet ( 5 ) at a second height level. The device comprises a substantially vertical conveyor duct ( 4 ), which is arranged to contain a plurality of axially stacked products ( 2 ) and which forms a transport path from the intake ( 3 ) to the outlet ( 5 ), a sensor device arranged to provide a signal expressing that a product has been removed from the outlet ( 5 ) conveyor devices, arranged to perform a repeatable convey cycle for controlled conveying of a product to the outlet, and a control device, arranged to implement the convey cycle on the basis of the said signal. In a preferred embodiment the conveyor device' comprises a seat ( 6 ) which protrudes through a gap extending in the conveyor duct's longitudinal direction, and which is controllably movable in the conveyor duct's longitudinal direction, and in addition a blocking device ( 7 ).
Patent AU-2001292062-B2 (AU)
Title: Improved well testing system
Inventor: EDWARDS JEFFREY CHARLES
IPC: E21B17/18
Filed: 2001-10-04
Granted: 2006-11-16
Abstract: A well testing system and well testing method is described which can be operated as a closed system with no production of hydrocarbons outside the well or gas can be separated and flared at surface giving minimal environmental impact with the liquid hydrocarbon being re-injected. This is achieved by providing a string with at least two well conduits which may be arranged in a concentric or non-concentric parallel configuration. One conduit is used to produce formation fluids to surface or to produce/store unrepresentative initial flow products and the other conduit is used to store formation fluid. The storage conduit can be filled from the top (surface) or the bottom of the well. In a preferred arrangement a valve is provided between the storage conduit and the well annulus for well pressure control, and a shut-in or test valve, which is controllable from surface, is disposed in the non-storage production conduit. A flow control valve is provided at the lower end of the string or at surface and the size of the valve opening is controllable to allow formation fluid to enter the storage string at a controlled rate, so that the formation fluid flowing time is increased to maximize the radius of investigation into the formation to a similar order of magnitude of existing production tests and extended well tests, which are typically two to three times the order of magnitude of the radius of investigation of a wireline formation test. Other aspects and embodiments of the invention are described.
Patent AU-2002233357-B2 (AU)
Title: Determining the risk of caries in a patient
Inventor: BOKENKAMP THOMAS
IPC: C12Q1/26
Filed: 2002-02-22
Granted: 2007-03-01
Abstract: The invention relates to a method for the determination of the patient-related risk of caries by determination of lactic acid and/or lactate in saliva and to a method for the location-specific determination of the patient-related risk of caries.
Patent AU-2002243033-B2 (AU)
Title: Liquid filtering method and filtering system
Inventor: UCHI YUKIHIKO
IPC: A61M1/36
Filed: 2002-04-02
Granted: 2006-02-02
Abstract: The present invention relates to a liquid filtering method for removing undesirable components such as aggregates and leukocytes from a liquid such as blood. In particular, the present invention relates to a filtering method for blood for removing micro aggregates and leukocytes which may cause blood transfusion side effects from whole blood products, red cell products, platelet products, plasma products, and the like used for blood transfusion.
Patent AU-2002250971-B2 (AU)
Title: Teeth cleaning device
Inventor: HILSCHER ALEXANDER
IPC: A61C17/00
Filed: 2002-02-19
Granted: 2006-10-26
Abstract: The invention relates to a handle (10) of an electric teeth cleaning device comprising a coupling element (30) for mechanically coupling a brush (20), a drive (22) for the brush (20) and a control function (18) for the drive (22), said control function (18) comprising an operation locking function (36), which can be activated and deactivated by a release function (38), in particular of the brush (20). The handle (10) has a read function (44) and a coil (46) as a coupling function for the contactless transmission and reading of single or multiple data of the release function (38). The operation locking function (36) is activated or deactivated in accordance with an output signal of the read function (44).
Patent AU-2003204620-B2 (AU)
Title: Adjustment of Ventilator Pressure-Time Profile to Balance Comfort and Effectiveness
Inventor: MALOUF GORDON
IPC: A61M16/00
Filed: 2003-06-11
Granted: 2006-04-27
Abstract: The invention is a ventilator whose servo-controller adjusts the degree of support by adjusting the profile of the pressure waveform as well as the pressure modulation amplitude. As the servo-controller increases the degree of support by increasing the pressure modulation amplitude, it also generates a progressively more square, and therefore efficient, pressure waveform; when the servo-controller decreases the degree of support by decreasing the pressure modulation amplitude, it also generates a progressively more smooth and therefore comfortable pressure waveform.
Patent AU-2003225253-B2 (AU)
Title: Drugs for mitigating taxane-induced neurotoxicity
Inventor: HAUSHEER FREDERICK H
IPC: A61P39/02
Filed: 2003-04-29
Granted: 2008-09-04
Abstract: Provided are pharmaceutical drugs for preventing or mitigating adverse actions associated with taxane antineoplastic drugs which are frequently and widely used in cancer chemotherapy, and pharmaceutical compositions which allow us to shorten the duration of treatment with taxane antineoplastic agents and/or to repeat the taxane treatment course more times, as well as drugs suitable for the therapeutic schedules.
Patent AU-2003275872-B2 (AU)
Title: Methods and device for preferably selecting a communication network which makes data service available
Inventor: HIND HUGH
IPC: H04L12/28
Filed: 2003-10-30
Granted: 2008-06-12
Abstract: Network selection techniques for use in a mobile device which is configured for voice and packet data communications are described. The mobile device performs a scanning operation to identify one or more communication networks, and consults a network selection list for selecting, in accordance with assigned priorities of the list, one of the identified networks. The mobile device also determines whether a packet data service interconnection to a home network via the selected network is available. If the interconnection to the home network via the selected network is determined to be available, then the mobile device operates with voice and packet data services in the selected network. Otherwise, if the interconnection to the home network via the selected network is determined to be unavailable, then the mobile device repeats the acts of consulting and determining for the next identified network in the list.
Patent AU-2004317667-B2 (AU)
Title: Long-piston hydraulic machines
Inventor: GLEASMAN KEITH E
IPC: F04B1/29
Filed: 2004-10-12
Granted: 2009-02-12
Abstract: Smaller and lighter hydraulic pump/motors provide remarkably improved volumetric efficiency with pistons having body portions substantially as long as the axial length of the respective cylinders in which they reciprocate. A plurality of respective lubricating channels form a single, continuous lubricating passageway entirely within the cylinder block and not connected by either fluid "input" or fluid "output" passageways, being replenished solely by a minimal flow of fluid to and from the valve end of each cylinder and passing between each respective cylindrical wall of each cylinder and the axial cylindrical body of each respective piston. Several embodiments are disclosed in combination with various spring-biased hold-down assemblies. The preferred embodiment includes a fixed cylinder block, a roller bearing mounting between the wobbler and rotor of a split-swash plate, with piston shoes contacting the wobbler directly without any intermediary apparatus.
Patent AU-2005201301-B2 (AU)
Title: Joint endoprosthesis with ambient condition sensing
Inventor: LIAO YEN-SHUO
IPC: A61B5/00
Filed: 2005-03-24
Granted: 2011-07-28
Abstract: A system for monitoring the ambient conditions of a mammalian joint, and particularly a joint that has been instrumented with a joint endoprosthesis includes a sensor supported by a component of the joint endoprosthesis. The system includes a transmission 5 element that is also supported within the body of the patient, preferably within the endoprosthesis. The transmission element transmits a signal indicative of the sensed ambient condition within the instrumented joint. For example, the sensor can be a temperature sensor used to evaluate the temperature within a joint, such as a hip joint, during activity or exercise by the patient.
Patent AU-2005221782-B2 (AU)
Title: Method for the production of profiles of a light metal material by means of extrusion
Inventor: SILLEKENS WIM
IPC: B21C23/00
Filed: 2005-03-03
Granted: 2010-10-14
Abstract: The method of producing profiled extrusion is magnesium or other light metal uses a press assembly (10) to force the blank material through a die (14) with the required profile (16). The blank light metal uses a grain refining additive such as Zirconium, strontium or calcium. The grain refiner can be a rare earth metal.
Patent AU-2005227073-B2 (AU)
Title: Chemically stable compositions of 4-hydroxy tamoxifen
Inventor: RICHARD FEDYNEC
IPC: A61P35/00
Filed: 2005-03-18
Granted: 2011-06-23
Abstract: A class of chemically stable 4-hydroxy tamoxifen compositions is characterized by roughly equal amounts of the Z-4-hydroxy tamoxifen and E-4-hydroxy tamoxifen isomers, such that the potency of the compositions is not affected adversely by the isomerization that occurs between these two forms. The inventive compositions are useful for preventing or for treating medical conditions.
Patent AU-2005240846-B2 (AU)
Title: 3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands
Inventor: MARTIN DENTON STEPHEN
IPC: C07D405/06
Filed: 2005-04-19
Granted: 2011-08-25
Abstract: The invention relates to 3- or 4-monosubstituted phenol and thiophenol derivatives of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. Said 3- or 4-monosubstituted phenol and thiophenol derivatives are H ligands and are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
Patent AU-2005261866-B2 (AU)
Title: 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-NACHR ligands for the treatment of CNS diseases
Inventor: TROXLER THOMAS J
IPC: C07D453/02
Filed: 2005-07-13
Granted: 2009-12-10
Abstract: The present invention relates to 1-aza-bicycloalkyl derivatives of formula (I)   
wherein the substituents are as defined in the specification, to processes for their production, their use as pharmaceuticals in the prevention and treatment of psychotic and neurodegenerative disorders. The claimed compounds act as nicotinic acelylcholine receptors (NACHR) ligands.
Patent AU-2005315337-B2 (AU)
Title: Pharmaceutical compounds and compositions
Inventor: LULLA AMAR
IPC: A61P11/06
Filed: 2005-12-19
Granted: 2012-07-05
Abstract: The invention provides three polymorphic forms of crystalline levosalbutamol sulphate designated herein as Forms (I), (II) and (III). Crystalline levosalbutamol sulphate Form I is characterised by a powder XRD pattern with peaks at 10.8, 11.9, 13.0, 18.3, 28.5 ± 0.2 degrees 2 theta. Crystalline levosalbutamol sulphate Form (II) is characterised by a powder XRD pattern with peaks at 8.7, 9.6, 15.2, 15.7, 19.1, 27.2, 30.7 ± 0.2 degrees 2 theta. Crystalline levosalbutamol sulphate Form (III) is characterised by a powder XRD pattern with peaks at 5.5, 6.9, 7.3, 18.7 ± 0.2 degrees 2 theta. Processes for making the new polymorphic forms and pharmaceutical compositions comprising them are also provided. A pharmaceutical composition comprises a therapeutically effective isomer of salbutamol or a salt, solvate, ester, derivative or polymorph thereof, a glucocorticoid and a pharmaceutically acceptable carrier or excipient and optionally one or more other therapeutic agents. Preferably the composition is an aerosol formulation comprising the drugs, a propellant and optionally one or more other ingredients, such as a surfactant, cosolvent, or bulking agent. Alternatively, DPI or inhalation suspensions may be used.
Patent AU-2006210117-B2 (AU)
Title: Method for producing a drug extract that contains hydroxystilbene
Inventor: CARL-FRIEDRICH SPAICH
IPC: A61K9/28
Filed: 2006-02-03
Granted: 2011-07-21
Abstract: The invention relates to a method for producing drug extracts that contain hydroxystilbene from a vegetable drug and to the use of various agents for pharmaceutical and non-pharmaceutical purposes.
Patent AU-2006214563-B2 (AU)
Title: Methods and compositions for impairing multiplication of HIV-1
Inventor: YVONNE STENBERG
IPC: A61K39/42
Filed: 2006-02-13
Granted: 2011-08-18
Abstract: A single isolated antibody or antibody fragment thereof binds to multiple variant sequences within an epitope of HIV-I Tat protein displayed in multiple strains and subtypes of HIV-I. This "pan-epitope" antibody is useful in therapeutic and prophylactic compositions and treatments of HIV-I infection, regardless of strain. This pan-epitope antibody is useful in assays for the detection of levels of HIV-I based on a measurement of the amount of Tat protein in a biological sample.